Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bacterial lysate - Lallemand Pharma

Drug Profile

Bacterial lysate - Lallemand Pharma

Alternative Names: Antibacterial vaccine sublingual - Lallemand Pharma; Bactovax; Bromunyl; Immubron; Ismigen; PIR-05; PMBL - Lallemand Pharma; Polyvalent Bacterial Mechanical Lysate - Lallemand Pharma; Provax; Pulmigen; Respibron; Sublingual antibacterial vaccine - Lallemand Pharma

Latest Information Update: 11 May 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Lallemand Pharma
  • Class Antibacterials; Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Chronic obstructive pulmonary disease; Respiratory tract infections
  • Phase III Allergic asthma

Most Recent Events

  • 11 May 2017 Phase-III development for Allergic asthma (In adolescents, In children) is ongoing in Poland (Sublingual) (Lallemand Pharma website, May 2017)
  • 24 Mar 2014 No development reported - Preregistration for Respiratory tract infections in Russia (Sublingual)
  • 09 Sep 2013 Phase-III clinical trials in Allergic asthma (in children and adolescents) in Poland (Sublingual) (EudraCT2013-000737-12)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top